Dashboard
Manage Tickers

RNA Avidity Biosciences, Inc.

Nasdaq aviditybiosciences.com


$ 69.90 $ 0.00 (0 %)    

Monday, 10-Nov-2025 16:16:03 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 623.82 $ 4.38 (0.71 %)
DIA $ 473.95 $ 1.94 (0.41 %)
SPY $ 681.69 $ 4.15 (0.61 %)
TLT $ 89.46 $ 0.06 (0.07 %)
GLD $ 380.15 $ 2.40 (0.64 %)
$ 69.84
$ 69.85
$ 69.50 x 100
$ 70.00 x 6
$ 69.77 - $ 69.87
$ 21.51 - $ 70.51
2,787,311
na
10.52B
$ 1.24
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-10-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 02-27-2025 01-01-1970 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-09-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 02-28-2024 12-31-2023 10-K
9 11-08-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 02-28-2023 12-31-2022 10-K
13 11-08-2022 09-30-2022 10-Q
14 08-09-2022 06-30-2022 10-Q
15 05-10-2022 03-31-2022 10-Q
16 03-01-2022 12-31-2021 10-K
17 11-09-2021 09-30-2021 10-Q
18 08-09-2021 06-30-2021 10-Q
19 05-12-2021 03-31-2021 10-Q
20 03-15-2021 12-31-2020 10-K
21 11-10-2020 09-30-2020 10-Q
22 08-11-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

avidity-biosciences-q3-eps-127-misses-111-estimate-sales-12475m-beat-1932m-estimate
Avidity Biosciences Q3 EPS $(1.27) Misses ...
11/10/2025 21:24:22

Avidity Biosciences (NASDAQ:RNA) reported quarterly losses of $(1.27) per share which missed the analyst consensus estimate of ...

1000-invested-in-avidity-biosciences-5-years-ago-would-be-worth-this-much-today
$1000 Invested In Avidity Biosciences 5 Ye...
10/29/2025 20:45:35

td-cowen-downgrades-avidity-biosciences-to-hold-lowers-price-target-to-74
TD Cowen Downgrades Avidity Biosciences to...
10/29/2025 13:03:20

TD Cowen analyst Ritu Baral downgrades Avidity Biosciences (NASDAQ:RNA) from Buy to Hold and lowers the price target from $7...

nucor-to-rally-more-than-14-here-are-10-top-analyst-forecasts-for-tuesday
Nucor To Rally More Than 14%? Here Are 10 ...
10/28/2025 11:48:22

this-boot-barn-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-tuesday
This Boot Barn Analyst Is No Longer Bullis...
10/28/2025 11:23:50

chardan-capital-downgrades-avidity-biosciences-to-neutral-lowers-price-target-to-72
Chardan Capital Downgrades Avidity Bioscie...
10/28/2025 11:16:10

Chardan Capital analyst Keay Nakae downgrades Avidity Biosciences (NASDAQ:RNA) from Buy to Neutral and lowers the price targ...

novartis-maintains-outlook-even-as-generics-bite-into-profits
Novartis Maintains Outlook Even As Generic...
10/28/2025 10:58:47

Novartis Q3 sales rose 8% to $13.91 billion, missing estimates, as Kisqali and Kesimpta drove growth while U.S. generics weighe...

rbc-capital-downgrades-avidity-biosciences-to-sector-perform-raises-price-target-to-72
RBC Capital Downgrades Avidity Biosciences...
10/28/2025 10:18:34

RBC Capital analyst Luca Issi downgrades Avidity Biosciences (NASDAQ:RNA) from Outperform to Sector Perform and raises the p...

merger-monday-makes-comeback-as-us-ma-tops-80-billion-in-24-hours
'Merger Monday' Makes Comeback As US M&A T...
10/28/2025 09:44:49

U.S. companies have struck more than $80 billion worth of deals in the past 24 hours, in the latest sign that mergers and acqui...

avidity-biosciences-soars-after-72-per-share-novartis-takeover
Avidity Biosciences Soars After $72 Per Sh...
10/27/2025 18:52:41

Avidity Biosciences (RNA) to be acquired by Novartis in a $12 billion cash deal. H.C. Wainwright downgrades to Neutral.

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
10/27/2025 17:05:57

citigroup-downgrades-avidity-biosciences-to-neutral-lowers-price-target-to-72
Citigroup Downgrades Avidity Biosciences t...
10/27/2025 16:43:39

Citigroup analyst Geoff Meacham downgrades Avidity Biosciences (NASDAQ:RNA) from Buy to Neutral and lowers the price target ...

raymond-james-downgrades-avidity-biosciences-to-market-perform
Raymond James Downgrades Avidity Bioscienc...
10/27/2025 15:22:24

Raymond James analyst Martin Auster downgrades Avidity Biosciences (NASDAQ:RNA) from Strong Buy to Market Perform.

janus-henderson-avidity-biosciences-bridgebio-pharma-and-other-big-stocks-moving-higher-on-monday
Janus Henderson, Avidity Biosciences, Brid...
10/27/2025 14:21:30

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
10/27/2025 12:06:22

booking-holdings-to-rally-around-12-here-are-10-top-analyst-forecasts-for-monday
Booking Holdings To Rally Around 12%? Here...
10/27/2025 12:00:54

this-harley-davidson-analyst-turns-bearish-here-are-top-5-downgrades-for-monday
This Harley-Davidson Analyst Turns Bearish...
10/27/2025 11:45:23

bernstein-downgrades-avidity-biosciences-to-market-perform-raises-price-target-to-72
Bernstein Downgrades Avidity Biosciences t...
10/27/2025 11:39:09

Bernstein analyst William Pickering downgrades Avidity Biosciences (NASDAQ:RNA) from Outperform to Market Perform and raises...

needham-downgrades-avidity-biosciences-to-hold-maintains-price-target-to-65
Needham Downgrades Avidity Biosciences to ...
10/27/2025 11:29:35

Needham analyst Joseph Stringer downgrades Avidity Biosciences (NASDAQ:RNA) from Buy to Hold and maintains the price target ...

hc-wainwright--co-downgrades-avidity-biosciences-to-neutral-lowers-price-target-to-72
HC Wainwright & Co. Downgrades Avidity Bio...
10/27/2025 10:44:58

HC Wainwright & Co. analyst Ananda Ghosh downgrades Avidity Biosciences (NASDAQ:RNA) from Buy to Neutral and lowers the ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION